Related trials
SORT-OUT-3, 2010 - zotarolimus eluting stent vs sirolimus eluting stent
SPIRIT IV, 2010 - everolimus eluting stent vs paclitaxel eluting stent
RESOLUTE All comers, 2010 - zotarolimus eluting stent vs everolimus eluting stent
BASKET-PROVE (EES), 2010 - everolimus eluting stent vs bare-metal stent
ISAR-DESIRE-2, 2010 - sirolimus eluting stent vs paclitaxel eluting stent
GISSOC II, 2010 - sirolimus eluting stent vs bare-metal stent
BASKET-PROVE (SES), 2010 - sirolimus eluting stent vs bare-metal stent
STICH (ventricular reconstruction), 2009 - CABG+surgical ventricular reconstruction vs CABG
ISAR TEST 2 (vs ZES), 2009 - dual sirolimus, probucol eluting stent vs zotarolimus eluting stent
SYNTAX, 2009 - paclitaxel eluting stent vs CABG
ISAR-LEFT-MAIN, 2009 - sirolimus eluting stent vs paclitaxel eluting stent
COMPARE, 2009 - everolimus eluting stent vs paclitaxel eluting stent
ISAR TEST 3 (PF), 2009 - polymer free sirolimus stent vs sirolimus eluting stent
PASEO, 2009 - drug-eluting stents vs bare-metal stent
ZEST AMI (vs PES), 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
ISAR TEST 2 (vs SES), 2009 - dual sirolimus, probucol eluting stent vs sirolimus eluting stent
BARI 2D, 2009 - CABG or PCI vs medical treatment
ISAR-TEST-4 (biodegradable polymer), 2009 - sirolimus biodegradable polymer vs sirolimus eluting stent
ISAR TEST 3 (BP), 2009 - sirolimus biodegradable polymer vs sirolimus eluting stent
GENIUS-STEMI, 2009 - Genous stent vs bare-metal stent
ENDEAVOR IV, 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
ZEST (vs SES), 2009 - zotarolimus eluting stent vs sirolimus eluting stent
ZEST AMI (vs SES), 2009 - zotarolimus eluting stent vs sirolimus eluting stent
Thiele, 2009 - sirolimus ES vs MIDCAB
ZEST (vs PES), 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
See also:
All coronary artery disease clinical trials
All stable angina clinical trials
All clinical trials of myocardial revascularization
All clinical trials of sirolimus eluting stent
|
|
Treatments
Studied treatment |
Sirolimus Eluting Stent
Cypher Select-TM
|
Control treatment |
Bare Metal Stent
SONIC-TM
|
Concomittant treatment |
clopidogrel for 6 months |
Patients
Patients |
patients with Chronic Total Occlusion older than 1 month, and successful recanalization |
Method and design
Randomized effectives |
78 / 74 (studied vs. control) |
Design |
Parallel groups |
Blinding |
open |
Follow-up duration |
8 months |
Number of centre |
13 |
Geographic area |
Italy |
Primary endpoint |
in-segment minimal luminal diameter |
Results
Endpoint
Studied treat. n/N
Control treat. n/N
Graph
RR [95% CI]
angiographic restenosis
8 / 78
50 / 74
0,15 [0,08;0,30]
2 yr TLR
35 / 78
6 / 74
classic
5,53 [2,47;12,38]
0
2
1.0
Relative risks
|
Endpoint |
Events (%) |
Relative Risk |
95% CI |
Endpoint definition in the trial |
Ref |
Studied treat. |
Control treat. |
angiographic restenosis
|
8 / 78 (10,3%) |
50 / 74 (67,6%) |
0,15 |
[0,08;0,30] |
|
|
2 yr TLR
|
35 / 78 (44,9%) |
6 / 74 (8,1%) |
5,53 |
[2,47;12,38] |
|
|
The primary endpoint (if exists) appears in blod characters
|
Reference(s) used for data extraction:
0:
|
Endpoint |
studied treat. |
control treat. |
mean diff |
Absolute risk reduction
|
Endpoint |
Events rate |
Absolute risk reduction (ARR) |
Studied treat. |
Control treat. |
angiographic restenosis |
10,26% |
67,57% |
-573,1‰
|
2 yr TLR |
44,87% |
8,11% |
36,8%
|
Meta-analysis of all similar trials:
Drug eluting stent in coronary artery disease for all type of patients
Drug eluting stent in coronary artery disease for total occlusion
myocardial revascularization in coronary artery disease for all type of patient
myocardial revascularization in stable angina for all type of patient
Reference(s)
-
Rubartelli P, Petronio AS, Guiducci V, Sganzerla P, Bolognese L, Galli M, Sheiban I, Chirillo F, Ramondo A, Bellotti S.
Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial..
Eur Heart J 2010;:
- 10.1093/eurheartj/ehq199
Pubmed
|
Hubmed
| Fulltext
|